Template:Hyperlipoproteinemia: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Lipoprotein disorders| Lipoprotein Disorders Main Page]]
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


Line 6: Line 11:
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"


|- bgcolor="Pink"
!
[[Hypercholesterolemia (patient information)|Hypercholesterolemia Patient Information]]
|-
!
!
|- bgcolor="Coral"
 
|- bgcolor="Pink"
!
!
[[Lipid disorders|Lipid Disorders Main Page]]
[[Hypertriglyceridemia (patient information)|Hypertriglyceridemia Patient Information]]
|-  
|-  
!
!


|- bgcolor="LightCoral"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia|Hyperlipoproteinemia Main Page]]
[[Hyperlipoproteinemia#Overview|Overview]]
|-  
|-  
!
!
Line 21: Line 32:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia (patient information)|Patient Information]]
[[Hyperlipoproteinemia#Classification|Classification]]
:'''[[Familial hyperchylomicronemia]]'''
:'''[[Familial hypercholesterolemia]]'''
:'''[[Familial combined hyperlipidemia]]'''
:'''[[Dysbetalipoproteinemia]]'''
:'''[[Primary hypertriglyceridemia]]'''
:'''[[Mixed hyperlipoproteinemia]]'''
|-  
|-  
!
!
Line 27: Line 44:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia#Overview|Overview]]
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
|-  
|-  
!
!
Line 33: Line 50:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Hyperlipoproteinemia#Classification|Classification]]
[[Hyperlipoproteinemia#Screening|Screening]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="CadetBlue"
!
!
[[Hyperlipoproteinemia#Synopsis|Synopsis]]
'''ACC/AHA Guideline Recommendations'''
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]]
[[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Diagnostic Algorithm|Diagnostic Algorithm]]
[[ACC AHA guideline on the treatment of blood cholesterol|Treatment]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
[[Hyperlipoproteinemia#Screening|Screening]]
[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]]
|-  
|-  
!
!


|- bgcolor="LightCoral"
|- bgcolor="PaleTurquoise"
!
!
'''Primary Hyperlipoprotein Disorders:'''
[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type I - [[Familial hyperchylomicronemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type II'''
[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
::'''Type IIA - [[Familial hypercholesterolemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
::'''Type IIB - [[Familial combined hyperlipidemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type III - [[Dysbetalipoproteinemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type IV - [[Primary hypertriglyceridemia]]'''
[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]]
|-  
|-  
!
!


|- bgcolor="Pink"
|- bgcolor="PaleTurquoise"
!
!
:'''Type V - [[Mixed hyperlipoproteinemia]]'''
[[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]]
|-  
|-  
!
!
|}
|}

Latest revision as of 14:41, 3 March 2017

Lipoprotein Disorders Main Page

Hyperlipoproteinemia Microchapters

Hypercholesterolemia Patient Information

Hypertriglyceridemia Patient Information

Overview

Classification

Familial hyperchylomicronemia
Familial hypercholesterolemia
Familial combined hyperlipidemia
Dysbetalipoproteinemia
Primary hypertriglyceridemia
Mixed hyperlipoproteinemia

Differential Diagnosis

Screening

ACC/AHA Guideline Recommendations

Summary

Treatment

Major recommendations for statin therapy

Therapeutic response to statin therapy

Blood cholesterol LDL and non-HDL treatment goals

Treatment in heart failure and hemodialysis

Primary prevention

Secondary prevention

Intensity of statin therapy in primary and secondary prevention

Safety Recommendations

Guideline on Lifestyle Management

Retrieved from "https://www.wikidoc.org/index.php?title=Template:Hyperlipoproteinemia&oldid=1297909"